What are Brokerage Firms Saying About Seres Therapeutics Inc (NASDAQ:MCRB)?

Seres Therapeutics Inc (NASDAQ:MCRB) has a current consensus EPS estimate for the  quarter of $-0.65 based on Street analyst predictions. The company is scheduled to next report earnings information on or around 2017-02-23 for the period ending 2016-12-31. In the same quarter last year, the company reported EPS of $-0.41. 

No Data 

Leave a Comment